Duchenne muscular dystrophy (DMD) is an inherited degenerative muscle disease for which there is currently no cure. It is caused by mutations in the gene encoding dystrophin, a cytoskeletal protein involved in maintaining the integrity of sarcolemma (muscle membrane) during muscle contraction. Defects in dystrophin lead to fragility of sarcolemma, which results in muscle dysfunction and degeneration. In normal conditions, satellite cells – a muscle-specific stem cell population – proliferate in response to damage and drive muscle regeneration; however, these cells are progressively depleted in DMD, hampering muscle repair capability. In this study, Shihuan Kuang and colleagues used mdx mice (an established model of DMD) to clarify the mechanisms responsible for satellite cell depletion in dystrophy. Whereas in young mice satellite cells could be activated in response to muscle degeneration, their number and self-renewal ability rapidly decreased with age of the mice. The age-dependent decline in satellite cell number and activity was linked with defects in Notch signalling, an evolutionarily conserved pathway involved in muscle stem cell function. Interestingly, artificial activation of Notch signalling resulted in successful restoration of the self-renewal ability of mdx satellite cells. This study implicates Notch signalling as a key pathway for preserving stem cell function in dystrophic muscles, and suggests that this pathway might be modulated to improve long-term satellite regenerative function in DMD. Page 997
Notch signalling restores satellite stem cell activity in a model of DMD
Notch signalling restores satellite stem cell activity in a model of DMD. Dis Model Mech 1 August 2014; 7 (8): e0803. doi:
Download citation file:
Advertisement
Cited by
Call for Papers – Infectious Disease: Evolution, Mechanisms and Global Health
Showcase your latest research on our upcoming Special Issue: Infectious Disease: Evolution, Mechanisms and Global Health. This issue will be coordinated by DMM Editors Sumana Sanyal and David Tobin alongside Guest Editors Judi Allen and Russell Vance. The deadline for submitting articles to this Special Issue has been extended to Monday 24 February 2025.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate a DMM programme on antimicrobial resistance on 26 March 2025. Find out more and register to join us in March 2025 in Liverpool, UK. The deadline for abstract submission and early-bird registration is 17 January 2025.
It's about time: the heterochronic background for the 2024 Nobel Prize in Physiology or Medicine
In this Editorial, Bruce Wightman writes about the groundwork laid by investigating the timing of developmental events in nematodes which led to the 2024 Nobel Prize in Physiology or Medicine.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Other journals from
The Company of Biologists